Company intelligence / Profile preview
Photocure
Oslo, Norwayphotocure.com ↗
- Ownership
- Public · PHO
- Employees
- ~70
- Development stage
- Commercial
01
Overview
Photocure’s lead product, Hexvix/Cysview, is approved and commercialized in multiple regions as an adjunct diagnostic tool to improve detection of non-muscle invasive bladder cancer via blue light cystoscopy. Clinical data show improved risk stratification and reduced recurrence rates when used alongside standard white-light cystoscopy. Cevira, a drug-device combination targeting HPV-induced cervical lesions, is in Phase II clinical development[2][5].
- Therapeutic areas
- Women's HealthOncology
- Modalities
- DeviceSmall molecule (photodynamic agents)Drug-device combination therapy
- Industry
- Biotech
02
Drug pipeline
3 assets2 more assets in the full pipeline.
Request access →03
Partnerships
Asieris Pharmaceuticals – partnership for Hexvix Phase III trial in China and license agreement to develop/commercialize Cevira[2]Richard Wolf GmbH – strategic agreement to co-develop flexible blue light cystoscope devices based on System blue technology[4]Juno Pharmaceuticals – distribution partner in Canada/Australia/New Zealand [2]BioSyent Pharma – distribution partner [2]Endotherapeutics Group – commercialization/distribution of Hexvix in Australia/New Zealand [2]
04
Financials
- Market cap
- $1.9B
- Enterprise value
- $1.9B
Beyond the preview
Go deeper on Photocure.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Photocure.